Cognitive Dysfunction in Multiple Sclerosis: Impacts and the Role of Psychotherapy in Symptom Management

Oct 26, 2025 | Multiple Sclerosis

Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative disease of the central nervous system. While physical symptoms like gait impairment and fatigue are well-recognized, cognitive dysfunction is now established as a common and debilitating feature, affecting 40% to 65% of patients across the disease spectrum (Benedict et al., 2020). This cognitive impairment stems directly from widespread demyelination, gray matter atrophy, and lesion load in critical brain networks (Rocca et al., 2015). Unlike global neurodegenerative conditions, cognitive deficits in MS are typically characterized by a distinct pattern of impairment in specific domains, which profoundly impacts quality of life and functional independence (Chiaravalloti & DeLuca, 2008).

1. Understanding Cognitive Dysfunction in MS: Core Domains Affected

The cognitive profile of MS is selective, meaning some abilities remain intact while others are significantly compromised. Research has consistently identified several key domains that are most vulnerable.

  • Information Processing Speed: This is the most frequently impaired cognitive domain in MS. Patients exhibit a generalized slowing of mental operations, affecting the speed at which they can take in, process, and respond to information (DeLuca et al., 2015).

  • Memory and Learning: Deficits are prominent in the acquisition (learning) and retrieval of new information, rather than in the storage of remote memories. This is often linked to impairments in efficient initial encoding, which is dependent on processing speed and working memory (Chiaravalloti et al., 2013).

  • Executive Functions: This umbrella term encompasses high-level cognitive control processes. Impairments manifest as difficulties with planning, problem-solving, cognitive flexibility (e.g., task-switching), and abstract reasoning, which are crucial for goal-directed behavior (Dagenais et al., 2023).

  • Attention and Concentration: Patients often report and demonstrate problems with sustained attention, particularly in the presence of distractions, and show significant challenges with divided attention, which is the ability to manage multiple streams of information simultaneously (DeLuca et al., 2015).

  • Visuospatial Abilities: A subset of individuals may experience difficulties with visual perception and spatial reasoning, which can contribute to problems with navigation and depth perception (Benedict et al., 2020).


2. The Profound Multifaceted Impacts of Cognitive Dysfunction

The ramifications of cognitive impairment extend far beyond neuropsychological test scores, permeating occupational, social, and personal spheres, and serving as a primary determinant of overall well-being.

  • Occupational Impact: Cognitive dysfunction is a leading cause of unemployment in PwMS. Difficulties with processing speed, memory, and executive functions directly reduce work efficiency and productivity, often necessitating job modifications or premature departure from the workforce (Kobelt et al., 2017).

  • Social and Interpersonal Impact: Communication can become strained due to word-finding difficulties (anomia) and an inability to follow complex conversations. These challenges are frequently misinterpreted by others as inattention or disinterest, leading to significant strain on personal relationships and increased social isolation (Goverover et al., 2018).

  • Personal and Emotional Impact: The ability to live independently is threatened when cognitive deficits affect instrumental activities of daily living (IADLs), such as managing finances, medications, and household tasks. This loss of autonomy, coupled with the “invisible” nature of these symptoms, is a major contributor to elevated rates of depression, anxiety, and frustration .


3. The Role of Psychotherapy and Behavioral Interventions in Symptom Management

While pharmacologic options for cognitive deficits in MS are limited, a growing body of evidence supports the efficacy of non-pharmacological, psychotherapeutic interventions. These approaches do not aim to cure the underlying neural damage but to mitigate its functional and emotional consequences through strategy training and psychological support.

  • Cognitive Rehabilitation Therapy (CRT): CRT is a systematic, evidence-based approach that directly targets cognitive deficits.

    • The compensatory approach, which has stronger empirical support than restorative drills, focuses on teaching patients to use internal and external strategies to bypass their cognitive limitations. This includes the rigorous use of smartphones and planners as external aids, and training in techniques like chunking and elaborative rehearsal to improve memory encoding (Chiaravalloti & Goverover, 2019; Goverover et al., 2018).

  • Cognitive-Behavioral Therapy (CBT): CBT addresses the pervasive emotional sequelae of cognitive dysfunction.

    • It helps patients identify and reframe maladaptive thoughts (e.g., “My brain is broken”) that exacerbate emotional distress. By treating co-morbid depression and anxiety, CBT can free up cognitive resources that were otherwise consumed by negative emotional states, thereby improving functional cognitive performance (Fischer et al., 2021).

  • Acceptance and Commitment Therapy (ACT): ACT offers a complementary framework to CBT by focusing on psychological flexibility.

    • It encourages patients to accept difficult thoughts and feelings about their cognitive changes without judgment, while simultaneously committing to actions that align with their personal values. This reduces the struggle with symptoms and promotes engagement in meaningful life activities despite cognitive challenges (Nordin & Rorsman, 2012).

  • Mindfulness-Based Interventions (MBIs): MBIs provide practical training in attentional regulation.

    • Regular mindfulness practice, which involves anchoring attention to the present moment (e.g., on the breath), has been shown to improve attentional control, reduce distractibility, and lower stress levels, all of which can have a beneficial effect on cognitive symptoms (Simpson et al., 2022).


Conclusion: Toward an Integrated, Biopsychosocial Model of Care

Cognitive dysfunction is a core component of Multiple Sclerosis with profound and wide-ranging consequences. A comprehensive treatment paradigm must integrate disease-modifying therapies with targeted, evidence-based psychotherapeutic interventions. Cognitive Rehabilitation provides the tools for functional adaptation, while CBT, ACT, and mindfulness address the critical emotional and psychological dimensions. This multi-faceted approach empowers individuals with MS to develop effective compensatory strategies, enhance psychological resilience, and ultimately improve their quality of life by managing both the visible and invisible symptoms of the disease (Benedict et al., 2020; Kesselring & Beer, 2021).

References

Benedict, R. H. B., Amato, M. P., DeLuca, J., & Geurts, J. J. G. (2020). Cognitive impairment in multiple sclerosis: Clinical management, MRI, and therapeutic avenues. The Lancet Neurology, 19(10), 860–871. https://doi.org/10.1016/S1474-4422(20)30277-5

Chiaravalloti, N. D., & DeLuca, J. (2008). Cognitive impairment in multiple sclerosis. The Lancet Neurology, 7(12), 1139–1151. https://doi.org/10.1016/S1474-4422(08)70259-X

Chiaravalloti, N. D., & Goverover, Y. (2019). Cognitive rehabilitation in multiple sclerosis: The role of memory. Neurodegenerative Disease Management, 9(2), 91–104. https://doi.org/10.2217/nmt-2018-0044

Chiaravalloti, N. D., Ibarretxe-Bilbao, N., DeLuca, J., Rusu, O., Pena, J., García-Gorro, C., & Ojeda, N. (2013). The source of the memory impairment in multiple sclerosis: Evidence from the context memory battery. Journal of Clinical and Experimental Neuropsychology, 35(10), 1029–1037. https://doi.org/10.1080/13803395.2013.847448

Dagenais, E., Rouleau, I., Demers, M., & Jobin, C. (2023). Characterizing executive functions in daily life in multiple sclerosis: A systematic review. Archives of Clinical Neuropsychology, 38(1), 1–19. https://doi.org/10.1093/arclin/acac045

DeLuca, J., Chiaravalloti, N. D., & Sandroff, B. M. (2015). Treatment and management of cognitive dysfunction in multiple sclerosis. Nature Reviews Neurology, 11(7), 394–404. https://doi.org/10.1038/nrneurol.2015.100

Fischer, A., Schröder, J., & Vettorazzi, E. (2021). Effects of psychological interventions on cognitive function in patients with multiple sclerosis: A meta-analysis. Multiple Sclerosis and Related Disorders, 52, 102970. https://doi.org/10.1016/j.msard.2021.102970

Goverover, Y., Chiaravalloti, N. D., & DeLuca, J. (2018). The relationship between self-awareness of neurobehavioral symptoms, cognitive functioning, and emotional symptoms in multiple sclerosis. Multiple Sclerosis Journal, 24(7), 947–955. https://doi.org/10.1177/1352458517709885

Kesselring, J., & Beer, S. (2021). Symptomatic therapy and neurorehabilitation in multiple sclerosis. The Lancet Neurology, 20(1), 68–80. https://doi.org/10.1016/S1474-4422(20)30435-5

Kobelt, G., Thompson, A., Berg, J., Gannedahl, M., & Eriksson, J. (2017). New insights into the burden and costs of multiple sclerosis in Europe. Multiple Sclerosis Journal, 23(8), 1123–1136. https://doi.org/10.1177/1352458517694432

Nordin, L., & Rorsman, I. (2012). Cognitive behavioural therapy in multiple sclerosis: A randomized controlled pilot study of acceptance and commitment therapy. Journal of Rehabilitation Medicine, 44(1), 87–90. https://doi.org/10.2340/16501977-0908

Rocca, M. A., Amato, M. P., De Stefano, N., Enzinger, C., Geurts, J. J., Penner, I. K., Rovira, A., Sumowski, J. F., & Filippi, M. (2015). Clinical and imaging assessment of cognitive dysfunction in multiple sclerosis. The Lancet Neurology, 14(3), 302–317. https://doi.org/10.1016/S1474-4422(14)70250-9

Simpson, R., Mair, F. S., & Mercer, S. W. (2022). Mindfulness-based interventions for people with multiple sclerosis: A systematic review and meta-ethnography. Disability and Rehabilitation, 44(11), 2231–2244. https://doi.org/10.1080/09638288.2020.1830212